Discover how targeted therapies are transforming precision oncology by matching cancer treatments to genetic mutations, enabling more personalized and effective care.
Learn how targeted therapies match drugs to cancer-driving mutations, advancing precision oncology and improving treatment outcomes.
Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case.
Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring.
Shraddha HakaniPrecision medicine in oncology is no longer a distant vision- it is a critical necessity. As cancer care evolves, biomarker-driven diagnostics, genomic sequencing, digital pathology, and AI-powered insights are transforming how clinicians detect.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.
